Research news

New method could help to find the best treatment for a pediatric cancer

A study led by IBEC researchers from the Nanobioengineering group, uses a functional predictive biomarker to anticipate the effect of treatments against rhabdomyosarcoma, the most common soft-tissue cancer affecting childhood and adolescence.

This advance can help in predicting treatment efficiency thus, avoiding tumor resistance and decreasing undesired secondary effects.

Read more…

Research news

3D printed hydrogels for cancer immunotherapy T-cell growth

The new 3D hydrogels provide high rates of cell proliferation, as they mimic lymph nodes, where T-cells reproduce in vivo. A new project, led by researchers from ICMAB and IBEC, and with the collaboration of VHIO and UIC, wants to transfer this technology to hospitals.

Cancer immunotherapy is based on using and strengthening the patient’s own immune system to recognize and fight tumor cells, without damaging healthy tissues.

Read more…

Other news

IBEC alumni Riccardo Levato, awarded with an ERC starting grant

Since its foundation in 2006, IBEC has been growing and consolidating as a leading research center. This has only been possible thanks to the work, talent, commitment and motivation of each and every one of the people who are and have been part of IBEC’s big family.

Now, Riccardo Levato, former researcher at IBEC, has been awarded with an ERC starting grant at UMC Utrecht to develop his project named “VOLUME-BIO”.  

Read more…

Other news

Back to school, back to the lab!

The holidays are over and it’s time to go back to work, also for our youngest and curious minds of the students that visit us every year. Despite the situation we are experiencing due to the coronavirus outbreak, at the Institute for Bioengineering of Catalonia (IBEC) we are making an effort to resume some of our outreach activities in person.

In this sense, the IBEC laboratories have reopened the doors for the students participating in the “Bojos per la Bioenginyeria” and the “Batx2Lab” programs, adapting to this “new normality”.

Read more…